MeSH Browser

MeSH Supplementary: PE regimen
Unique ID: C075609
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C075609
Registry Numbers: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin
Frequency: 12
Note: chemotherapy protocol consisting of above cpds; used in the treatment of symptomatic advanced non-small-cell lung cancer; PE protocol consists of CISPLATIN & ETOPOSIDE
Source: Cancer Chemother Pharmacol 1992;30(3):212-4
Date of Entry: 1992/08/12
Revision Date: 2000/11/30

PE regimen MeSH Supplementary Concept Data 2025